PRO-ving Ground: FDA Review Teams Commit to Patient-Reported Outcomes
This article was originally published in RPM Report
Executive Summary
FDA recently announced a significant step in furthering the development of patient-reported outcomes: the planned creation of a web-based compendium of clinical outcomes assessments, including PROs. But an even more significant sign that FDA is committed to developing new patient-reported endpoints came directly from reviewers – including some divisions that have not historically been out front on the issue.